CSL Limited: all 268 studies
Page 3 of 3. Open to participants first (19), then studies with results posted, then the rest; newest registration first within each.
- Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 RecipientsActive, not recruitingNCT02390297
- An Observational Cohort Study to Investigate the Risk of Thromboembolic Events in Patients Receiving Kcentra® or Plasma to Reverse Vitamin K Antagonist (VKA) Therapy in the Setting of Acute Major BleedingCompletedNCT02319460
- Study of a Prothrombin Complex Concentrate for Rapid Reversal of Coagulopathy Induced by Vitamin K Antagonists in Japanese SubjectsCompletedNCT02281201Phase 3
- Flucelvax Pregnancy RegistryWithdrawnNCT02258178
- Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in Elderly Subjects 65 Years of Age and AboveCompletedNCT02126761Phase 1
- Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza VaccineCompletedNCT02107807Phase 3
- Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical ConditionsCompletedNCT02091908Phase 3
- A Study to Evaluate the Safety and Pharmacokinetics of Two Formulations of C1-esterase InhibitorCompletedNCT01760343Phase 1
- A Study of CSL362 in Patients With CD123+ Acute Myeloid Leukemia Currently in RemissionCompletedNCT01632852Phase 1
- A Safety and Pharmacokinetics Study of a Recombinant Fusion Protein Linking Coagulation Factor VIIa With Albumin (rVIIa-FP) in Healthy Male VolunteersCompletedNCT01542619Phase 1
- A Single Ascending Dose Study Examining the Safety and Pharmacokinetic Profile of Reconstituted High Density Lipoprotein (CSL112) Administered to PatientsCompletedNCT01499420Phase 2
- A Drug-Drug Interaction Study of Warfarin and PA21CompletedNCT01477424Phase 1
- A Drug-Drug Interaction Study of Digoxin and PA21CompletedNCT01477411Phase 1
- Study of Fibrinogen Concentrate (Human) (FCH) to Control Bleeding During Complex Cardiovascular SurgeryCompletedNCT01475669Phase 3
- Multicenter Study of Long-Term Clinical Outcomes of Subcutaneous Immune Globulin IgPro20 in Subjects With Primary Immunodeficiency (Japan Study)CompletedNCT01461018Phase 3
- A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron DeficiencyCompletedNCT01453608Phase 4
- A Drug-Drug Interaction Study of Omeprazole and PA21CompletedNCT01452906Phase 1
- Study of Biostate for Treatment of Children With Hemophilia A Complicated by Antibody DevelopmentTerminatedNCT01445197Phase 3
- A Drug-Drug Interaction Study of Furosemide and PA21CompletedNCT01438359Phase 1
- Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart FailureCompletedNCT01394562Phase 3
- Safety and Tolerability Study of Liquid Alpha1 Proteinase Inhibitor (API) in Subjects With Cystic FibrosisCompletedNCT01347190Phase 1
- A Drug-Drug Interaction Study of Losartan and PA21CompletedNCT01324752Phase 1
- A Multiple Ascending Dose Study of CSL112 in Healthy VolunteersCompletedNCT01281774Phase 1
- Safety and Pharmacokinetic Study of a Recombinant Coagulation Factor IX Albumin Fusion Protein in Subjects With Hemophilia BCompletedNCT01233440Phase 1
- Study of Biostate® in Children With Hemophilia ACompletedNCT01229007Phase 3
- Extension Study of Biostate in Subjects With Von Willebrand DiseaseCompletedNCT01224808Phase 3
- Study of Biostate® in Children With Von Willebrand DiseaseCompletedNCT01213446Phase 3
- Retrospective Chart Review of Subcutaneous IgG Use in InfantsCompletedNCT01166074
- Comparative Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) Versus Oral Iron for Iron Deficiency Anaemia in Pregnant WomenCompletedNCT01131624Phase 3
- Safety, Tolerability and Pharmacokinetics of CSL112 in Healthy VolunteersCompletedNCT01129661Phase 1
- Ferric Carboxymaltose Treatment to Improve Fatigue Symptoms in Iron-deficient Non-anaemic Women of Child Bearing AgeCompletedNCT01110356Phase 4
- Patient Registry Study of Berinert® in Normal Clinical PracticeCompletedNCT01108848
- Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing ChemotherapyCompletedNCT01101399Phase 3
- Ferric Carboxymaltose for Treatment of Anaemia of Cancer in Subjects With Multiple Myeloma Receiving ChemotherapyTerminatedNCT01100879Phase 4
- Rabies Immune Plasma Booster StudyCompletedNCT01063140
- Quality of Life Study of Helixate NexGenCompletedNCT01053715
- Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)CompletedNCT01053169
- Health Related Quality of Life of Youth and Young Adults With Hemophilia ACompletedNCT01034904
- Study of a pd VWF/FVIII Concentrate, Biostate®, in Subjects With Von Willebrand DiseaseCompletedNCT00941616Phase 2/3
- Fibrinogen Concentrate (Human) - Efficacy and Safety StudyWithdrawnNCT00916656Phase 3
- Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)TerminatedNCT00882414Phase 2
- Study of a pd vWF/FVIII, Biostate®, in Subjects With Haemophilia ACompletedNCT00879541Phase 2
- Safety, Efficacy and Pharmacokinetics Study of ALD518 in Patients With Active Rheumatoid ArthritisCompletedNCT00867516Phase 2
- Safety, Efficacy and Pharmacokinetics of ALD518 in Patients With Non-Small Cell Lung Cancer-related Fatigue and CachexiaCompletedNCT00866970Phase 2
- Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Influenza Antigen Dose, Adjuvant Dose, and Route of Administration in Healthy Elderly Individuals Ages 65 Years and OlderCompletedNCT00848848Phase 1
- EFfect of Ferric Carboxymaltose on exercIse CApacity and Cardiac Function in Patients With Iron deficiencY and Chronic Heart FailureTerminatedNCT00821717Phase 3
- Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived H5N1 Influenza Vaccine in Young Adults (18-40 Years Old)CompletedNCT00812019Phase 1
- FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-CORCompletedNCT00810030Phase 3
- Maintenance Treatment of Iron Deficiency in IBD PatientsCompletedNCT00810004Phase 3
- A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced)CompletedNCT00701545
- Haemocomplettan® P During Aortic ReplacementCompletedNCT00701142Phase 2
- A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric PopulationCompletedNCT00700193Phase 3
- Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary ImmunodeficiencyCompletedNCT00680446Phase 3
- Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)CompletedNCT00520780Phase 3
- A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly ParticipantsCompletedNCT00479648Phase 2
- Ig NextGen 10% in Patients With Primary Immune Deficiency (PID)CompletedNCT00405184Phase 3
- Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid LeukemiaCompletedNCT00401739Phase 1
- Subcutaneous Ig NextGen 16% in PID PatientsCompletedNCT00391131Phase 3
- Study of a Pandemic Influenza Vaccine in Elderly ParticipantsCompletedNCT00376402Phase 2
- Study of a Pandemic Influenza Vaccine in ChildrenCompletedNCT00370864Phase 2
- Ig NextGen 10% in Idiopathic Thrombocytopenic Purpura (ITP) PatientsCompletedNCT00362349Phase 3
- Phase II Study of Pandemic Influenza VaccineCompletedNCT00320346Phase 2
- Effect of rHDL on Atherosclerosis - Safety and Efficacy: THE ERASE TRIALCompletedNCT00225719Phase 2
- Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD)CompletedNCT00168090Phase 4
- Prothrombin Complex Concentrate for Anticoagulant ReversalCompletedNCT00168077Phase 3
- Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID)CompletedNCT00168025Phase 3
- Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID)CompletedNCT00168012Phase 3
- Study of a Pandemic Influenza VaccineCompletedNCT00136331Phase 1